Patents by Inventor Sergio Pumarola Segura

Sergio Pumarola Segura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10233206
    Abstract: The present invention belongs to the field of nutraceuticals or functional agents with immunostimulating capacity for triggering mechanisms of the innate immune response at a mucosal level. More specifically, it refers to the use of the compound D-fagomine as immunostimulating agent of the innate immune response in the mucosa and for the prevention or prophylaxis of inflammatory processes or diseases associated with an overactivation of the humoral immune response. The invention also relates to a composition comprising D-fagomine for the above referenced application.
    Type: Grant
    Filed: February 13, 2014
    Date of Patent: March 19, 2019
    Assignee: SERGIO PUMAROLA SEGURA
    Inventors: Sergio Pumarola Segura, Maria Carmen Antolin Mate, Marta Llopis Pages, Maria de los Angeles Calvo Torras
  • Patent number: 9226517
    Abstract: It comprises the use of D-fagomine or derivatives thereof in the prevention and/or coadjuvant treatment of bacterial infections, as well as to pharmaceutical, veterinary, or food and feed, pet food compositions containing them.
    Type: Grant
    Filed: March 24, 2011
    Date of Patent: January 5, 2016
    Assignee: Taihua Shouyue (Hong Kong) International Co Limited
    Inventors: Sergio Pumarola Segura, Josep Lluis Torres Simón
  • Publication number: 20150368283
    Abstract: The present invention belongs to the field of nutraceuticals or functional agents with immunostimulating capacity for triggering mechanisms of the innate immune response at a mucosal level. More specifically, it refers to the use of the compound D-fagomine as immunostimulating agent of the innate immune response in the mucosa and for the prevention or prophylaxis of inflammatory processes or diseases associated with an overactivation of the humoral immune response. The invention also relates to a composition comprising D-fagomine for the above referenced application.
    Type: Application
    Filed: February 13, 2014
    Publication date: December 24, 2015
    Inventors: Sergio Pumarola Segura, Maria Carmen Antolin Mate, Marta Llopis Pages, Maria de los Angeles Calvo Torras
  • Publication number: 20130116282
    Abstract: The buckwheat extract comprises a extract of buckwheat which are enriched in D-fagomine and including 3,4-di-epifagomine, a process for their preparation, pharmaceutical or veterinary compositions, dietary supplements or functional foods containing them, their use alone or in combination with saccharide, an iminocyclitol or probiotics, as a blood glucose levels controlling agent reducing the post-prandial glucose levels, as well as the buckwheat extract for use in the prevention and/or coadjuvant treatment of microbiota imbalance, that reduces the adhesion of some potentially harmful microorganism in the microbiota and therefore increasing the resistance to disease.
    Type: Application
    Filed: July 15, 2011
    Publication date: May 9, 2013
    Applicant: BIOGLANE, S.L.N.E.
    Inventors: Josep Lluis Torres Simón, Susana Amézqueta Pérez, Sergio Pumarola Segura, Pere Clapés Saborit
  • Publication number: 20130011344
    Abstract: It comprises the use of D-fagomine or derivatives thereof in the prevention and/or coadjuvant treatment of bacterial infections, as well as to pharmaceutical, veterinary, or food and feed, pet food compositions containing them.
    Type: Application
    Filed: March 24, 2011
    Publication date: January 10, 2013
    Applicant: BIOGLANE
    Inventors: Sergio Pumarola Segura, Josep Lluis Torres Simón